Policy / Pricing Eli Lilly issues data sharing ultimatum to 340B hospitals BioPharma DiveSelect hospitals have refused to share data to prove they re not double-dipping drug discounts, Lilly said.Read full story pharminent June 2, 2026 (Last updated: June 3, 2026) BioPharma Dive Select hospitals have refused to share data to prove they re not double-dipping drug discounts, Lilly said. Read full story Post navigation Previous: Fulcrum exploring a potential sale after FDA sidelined its sickle cell drugNext: ASCO26: In vivo CAR-Ts in the spotlight Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026